Impaired contact hypersensitivity reaction and reduced production of vascular endothelial growth factor in tumor necrosis factor-α gene-deficient mice

Journal of Dermatology

Volumn 32, Issue 7, 2005, Pages 523-533

  Shibata, Mari ^a   Sueki, Hirohiko ^a   Suzuki, Hirotake ^a   Watanabe, Hideaki ^a   Ohtaki, Hirokazu ^a   Shioda, Seiji ^a   Nakanishi Ueda, Takako ^a   Yasuhara, Hajime ^a   Sekikawa, Kenji ^b   Iijima, Masafumi ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF ANIMAL HEALTH   (Japan)

Author keywords

Angiogenesis; Contact hypersensitivity; Delayed type hypersensitivity; TNF ; VEGF

Indexed keywords

CD31 ANTIGEN; OXAZOLONE; PICRYL CHLORIDE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTACT ALLERGY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; EPIDERMIS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; MALE; MONONUCLEAR CELL; MORPHOMETRICS; MOUSE; NEUTROPHIL; NONHUMAN; SKIN BLOOD VESSEL; VASODILATATION;

EID: 23944440097     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2005.tb00794.x     Document Type: Article

References (48)

1. Piguet PF, Grau GE, Hauser C, et al: Tumor necrosis factor is a critical mediator in hapten-induced irritant and contact hypersensitivity reactions, J Med, 173: 673-679, 1991.
2. Cumberbatch M, Kimber I: Dermal tumor necrosis factor-α induces dendritic cell migration to draining lymph nodes, and possibly provides one stimulus for Langerhans cell migration, Immunology, 75: 257-263, 1992.
3. Kurimoto I, Streilein JW: Cis-urocanic acid suppression of contact hypersensitivity induction is mediated via tumor necrosis factor-α, J Immunol, 148: 3072-3078, 1992.
4. Streilein JW: Sunlight and skin-associated lymphoid tissues (SALT): If UVB is the trigger and TNF α is its mediator, what is the message?, J Invest Dermatol, 100: 47S-52S, 1993.
5. Cumberbatch M, Kimber I: Tumor necrosis factor-α is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitization, Immunology, 84: 31-35, 1995.
6. Simon JC, Edelbaum D, Bregstresser PR, et al: Distorted antigen-presenting function of Langerhans cells induced by tumor necrosis factor α via a mechanism that appears different from that induced by ultraviolet B radiation, Photodermatol Photoimmunol Photomed, 8: 190-194, 1991.
7. Bromberg JS, Chavin KD, Kunkel SL: Anti-tumor necrosis factor antibodies suppress cell-mediated immunity in vivo, J Immunol, 148: 3412-3417, 1992.
8. Kondo S, Wang B, Fujisawa H, et al: Effect of gene-targeted mutation in TNF receptor (p55) on contact hypersensitivity and ultraviolet B-induced immunosuppression, J Immunol, 155: 3801-3805, 1995.
9. Wang B, Kondo S, Shivji GM, et al: Tumor necrosis factor receptor II (p75) signaling is required for the migration of Langerhans cells, Immunology, 88: 284-288, 1996.
10. Amerio P, Toto P, Feliciani C, et al: Rethinking the role of tumor necrosis factor-α in ultraviolet (UV) B-induced immunosuppression: Altered immune response in UV-irradiated TNFR1R2 gene-targeted mutant mice, Br J Dermatol, 144: 952-957, 2001.
11. Pasparakis M, Alexopoulou L, Episkopou V, et al: Immune and inflammatory responses in TNF-α-deficient mice: A critical requirement for TNF-α in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response, J Exp Med, 184: 1397-1411, 1996.
12. Taniguchi T, Takata M, Ikeda A, et al: Failure of germinal center formation and impairment of response to endotoxin in tumor necrosis factor-α-deficient mice, Lab Invest, 77: 647-655, 1997.
13. Senger DR, Connolly DT, Van De Water L, et al: Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor, Cancer Res, 50: 1774-1778, 1990.
14. Maglione D, Guerriero V, Viglietto G, et al: Isolation of human placenta cDNA coding for a protein related to the vascular permeability factor, Proc Natl Acad Sci USA, 88: 9267-9271, 1991.
15. Connolly DT, Heuvelman DM, Nelson R, et al: Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis, J Clin Invest, 84: 1470-1478, 1989.
16. Weninger W, Uthman A, Pammer J, et al: Vascular endothelial growth factor production in normal epidermis and in benign and malignant epithelial skin tumors, Lab Invest, 75: 647-657, 1996.
17. Brown LF, Yeo KT, Berse B, et al: Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing, J Exp Med, 176: 1375-1379, 1992.
18. Detmar M, Brown LF, Claffey KP, et al: Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis, J Med, 180: 1141-1146, 1994.
19. Brown LF, Olbricht SM, Berse B, et al: Overexpression of vascular permeability factor (VPF/ VEGF) and its endothelial cell receptors in delayed hypersensitivity skin reactions, J Immunol, 154: 2801-2807, 1995.
20. Taraboletti G, Giavazzir: Modelling approach for angiogenesis, Eur J Cancer, 40: 881-889, 2004.
21. Sauder DN, Dekoven J, Champagne P, et al: Neovastat (AE-941), an inhibitor of angiogenesis: Randomised phase I/II clinical trial results in patient with plaque psoriasis, J Am Acad Dermatol, 47: 535-541, 2002.
22. Watanabe H, Mamelak AJ, Wang B, et al: Anti-VEGF receptor-2 (Flk-1/KDR) antibody suppresses contact hypersensitivity, Exp Dermatol, 13: 671-681, 2004.
23. Gaspari AA, Katz SI: Contact hypersensitivity, in Coligan JE, Kruisbeek AM, Margulies DH, et al (eds): Current Protocols in Immunology, John Wiley & Sons Inc, 1998, pp 4.2.1-4.2.5.
24. Rendl M, Mayer C, Weninger W, et al: Topically applied lactic acid increases spontaneous secretion of vascular endothelial growth factor by human reconstructed epidermis, Br J Dermatol, 145: 3-9, 2001.
25. Dovorak HF, Brown LF, Detmar M, et al: Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability and angiogenesis, Am J Pathol, 146: 1029-1039, 1995.
26. Detmar M, Brown LF, Schön MP, et al: Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice, J Invest Dermatol, 111: 1-6, 1998.
27. Staquet MJ, Godefroy S, Jacquet C, et al: Vascular endothelial growth factor (VEGF) induces human Langerhans cell migration, Arch Dermatol Res, 293: 26-28, 2001.
28. Gruber BL, Marchese MJ, Kew R: Angiogenic factors stimulate mast-cell migration, Blood, 86: 2488-2493, 1995.
29. Clauss M, Gerlach H, Gerlach J, et al: Vascular permeability factor: A tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration, J Exp Med, 172: 1535-1545, 1990.
30. Walsh LJ, Lavker RM, Murphy GF: Determinants of immune cell trafficking in the skin, Lab Invest, 63: 592-560, 1990.
31. Reinders ME, Sho M, Izawa A, et al: Proinflammatory functions of vascular endothelial growth factor in alloimmunity, J Clin Invest, 112: 1655-1665, 2003.
32. Oura H, Bertoncini J, Velasco P, et al: A critical role of placental growth factor in the induction of inflammation and edema formation, Blood, 101: 560-567, 2003.
33. Detmar M, Brown LF, Berse B, et al: Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/ VEGF) and its receptors in human skin, J Invest Dermatol, 108: 263-268, 1997.
34. Palacio S, Schmitt D, Viac J: Contact allergens and sodium lauryl sulfate upregulate vascular endothelial growth factor in normal keratinocytes, Br J Dermatol, 137: 540-544, 1997.
35. Blaudschun R, Sunderkotter C, Brenneisen P, et al: Vascular endothelial growth factor causally contributes to the angiogenic response upon ultraviolet B Irradiation in vivo, Br J Dermatol, 146: 581-587, 2002.
36. Weninger W, Rendl M, Mildner M, et al: Retinoids downregulate vascular endothelial growth factor/vascular permeability factor production by normal human keratinocytes, J Invest Dermatol, 111: 907-911, 1998.
37. Detmar M, Yeo KT, Nagy JA, et al: Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells, J Invest Dermatol, 137: 540-544, 1997.
38. Frank S, Hübner G, Breier G, et al: Regulation of vascular endothelial growth factor expression in cultured keratinocytes, J Biol Chem, 270: 12607-12613, 1995.
39. Longuet-Perret I, Schmitt D, Viac J: Tumour necrosis factor-α is involved in the contrasting effects of ultraviolet B and ultraviolet A1 radiation on the release by normal human keratinocytes of vascular permeability factor, Br J Dermatol, 138: 221-224, 1998.
40. Piguet PF, Grau GE, Vassalli P: Subcutaneous perfusion of tumor necrosis factor induces local proliferation of fibroblasts, capillaries, and epidermal cells, or massive tissue necrosis, Am J Pathol, 136: 103-110, 1990.
41. Messadi DV, Pober JS, Fiers W, et al: Induction of an activation antigen on postcapillary venular endothelium in human skin organ culture, J Immunol, 139: 1557-1562, 1987.
42. Kimber I, Cumberbatch M: Stimulation of Langerhans cell migration by tumor necrosis factor-α (TNF-α), J Invest Dermatol, 99: 48S-50S, 1992.
43. Jäättela M: Biologic activities and mechanisms of action of tumor necrosis factor-α/cachectin, Lab Invest, 64: 724-742, 1991.
44. Kupper TS: Mechanisms of cutaneous inflammation. Interaction between epidermal cytokines, adhesion molecules, and leukocytes, Arch Dermatol, 125: 1406-1412, 1989.
45. Waldorf HA, Walsh LJ, Schechter NM, et al: Early cellular events in evolving cutaneous delayed hypersensitivity in humans, Am J Pathol, 138: 477-486, 1991.
46. Bevilacqua MP, Pober JS, Mendrick DL, et al: Identification of an inducible endothelial-leukocyte adhesion molecule, Proc Natl Acad Sci USA, 84: 9238-9242, 1987.
47. Klein LM, Lavker RM, Matis WL, et al: Degranulation of human mast cells induces an endothelial antigen central to leukocyte adhesion, Proc Natl Acad Sci USA, 86: 8972-8976, 1989.
48. Walsh LJ, Trinchieri G, Waldorf HA, et al: Human dermal mast cells contain and release tumor necrosis factor α, which induce endothelial leukocyte adhesion molecule-1, Proc Natl Acad Sci USA, 88: 4220-4224, 1991.